EuroIntervention PCRonline - Connecting with the community

Alexandre Abizaid

69 articles

Assessment of long-term mortality in patients with complex coronary artery disease undergoing percutaneous intervention: comparison of multiple anatomical and clinical prognostic risk scores

EuroIntervention 2017;13:1177-1184 published online May 2017

Published in Volume 13 Number 10, November 2017

Transcatheter aortic valve implantation for mixed versus pure stenotic aortic valve disease

EuroIntervention 2017;13:1157-1165 published online July 2017

Published in Volume 13 Number 10, November 2017

Transfemoral TAVI using the self-expanding ACURATE neo prosthesis: one-year outcomes of the multicentre “CE-approval cohort”

EuroIntervention 2017;13:e1040-e1046 published online August 2017 published online e-edition October 2017

Published in Volume 13 Number 9, October 2017

Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III

EuroIntervention 2017;13:432-439 published online ahead of print May 2017

Published in Volume 13 Number 4, July 2017

The interaction of de novo and pre-existing aortic regurgitation after TAVI: insights from a new quantitative aortographic technique

EuroIntervention 2017;13:60-68 published online December 2016

Published in Volume 13 Number 1, May 2017

Pressure-mediated versus pharmacologic treatment of radial artery spasm during cardiac catheterisation: a randomised pilot study

EuroIntervention 2017;12:e2212-e2218 published online December 2016 published online e-edition April 2017

Published in Volume 12 Number 18, April 2017

DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial

EuroIntervention 2016;12:e1336-e1342 published online ahead of print October 2015 published online e-edition December 2016

Published in Volume 12 Number 11, December 2016

One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials

EuroIntervention 2016;12:1255-1262

Published in Volume 12 Number 10, November 2016

Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold

EuroIntervention 2015;11:141-148 published online ahead of print May 2015

Published in Volume 11 Number 2, June 2015

The ABS mother-daughter platforms

EuroIntervention 2015;11:V151-V152

Published in Volume 11 Supplement V, May 2015

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled

EuroIntervention 2015;10:1396-1401 published online ahead of print April 2014

Published in Volume 10 Number 12, April 2015

First-in-man assessment of the InSeal VCD, a novel closure device for large puncture accesses

EuroIntervention 2015;10:1391-1395 published online ahead of print December 2013

Published in Volume 10 Number 12, April 2015

In-stent neoatherosclerosis 10 years after bare metal stent implantation: ruptured vulnerable plaque by optical coherence tomography

EuroIntervention 2014;10:494 published online ahead of print November 2013

Published in Volume 10 Number 4, August 2014

Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial

EuroIntervention 2014;10:449-457 published online ahead of print January 2014

Published in Volume 10 Number 4, August 2014

Renal sympathetic denervation and ventricular arrhythmias: a case of electrical storm with multiple renal arteries

EuroIntervention 2014;10:166 published online ahead of print November 2013

Published in Volume 10 Number 1, May 2014

First-in-man randomised comparison of a novel sirolimus-eluting stent with abluminal biodegradable polymer and thin-strut cobalt-chromium alloy: INSPIRON-I trial

EuroIntervention 2014;9:1380-1384

Published in Volume 9 Number 12, April 2014

Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions

EuroIntervention 2013;9:721-729 published online ahead of print March 2013

Published in Volume 9 Number 6, October 2013

Symetis ACURATE TF™ aortic bioprosthesis

EuroIntervention 2013;9:S107-S110

Published in Volume 9 Supplement S, September 2013

First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial

EuroIntervention 2013;9:493-500

Published in Volume 9 Number 4, August 2013

Serial greyscale and radiofrequency intravascular ultrasound assessment of plaque modification and vessel geometry at proximal and distal edges of bare metal and first-generation drug-eluting stents

EuroIntervention 2012;8:225-234

Published in Volume 8 Number 2, June 2012

First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation

EuroIntervention 2012;8:43-50 publish online ahead of print March 2012

Published in Volume 8 Number 1, May 2012

Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial

EuroIntervention 2012;7:1301-1309

Published in Volume 7 Number 11, March 2012

Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry

EuroIntervention 2011;7:962-968

Published in Volume 7 Number 8, December 2011

PCI in patients with coronary artery disease and previous CABG: acute and long-term results

Published in Volume 7 Supplement M, May 2011

Angiographic and intravascular ultrasound predictors of side branch failure during PCI with provisional side branch stenting approach in complex coronary bifurcation lesions

Published in Volume 7 Supplement M, May 2011

Continuous neointimal hyperplasia formation after five years of different generations of DES: is there enough evidence of late ‘catch-up’?

Published in Volume 7 Supplement M, May 2011

Impact of arterial injury on neointimal hyperplasia after Zotarolimus-eluting stent implantation: an IVUS study

Published in Volume 7 Supplement M, May 2011

Comparative analysis of a distal protection system and the new stent M-Guard for the treatment of complex lesions in saphenous vein grafts

Published in Volume 7 Supplement M, May 2011

Advanced bifurcation systems mother-daughter platform, a novel system in treatment of coronary bifurcation lesions: preliminary results of the prospective, multicentre first-in-man experience

Published in Volume 7 Supplement M, May 2011

Complex coronary bifurcation lesions treated with the novel polymer-free dedicated bifurcation paclitaxel-eluting stent (Nile pax): clinical and angiographic clinical results of the prospective, multicentre bipax clinical trial

Published in Volume 7 Supplement M, May 2011

De novo coronary lesions treated with the novel polymer-free Biolimus-A9 coated stents: four- and twelve-month angiographic results from the prospective, randomised, multicentre BIOFREEDOM clinical trial

Published in Volume 7 Supplement M, May 2011

Preliminary results of the multicentric, double-blinded, randomised, Vestasync II trial

Published in Volume 7 Supplement M, May 2011

Randomised comparison of the efficacy and safety of a novel DES with biodegradable polymer and cobalt-chromium alloy - Inspiron I trial

Published in Volume 7 Supplement M, May 2011

First-in-man, multicentre assessment of the novel Acrobat Svelt balloon-expandable stent-on-a-wire system

Published in Volume 7 Supplement M, May 2011

Optimised duration of Clopidogrel therapy following treatment with the Endeavor Zotarolimus-eluting stents in the real-world clinical practice (OPTIMIZE) trial: rationale, design and preliminary blinded results of a large-scale, randomised, multicentre study

Published in Volume 7 Supplement M, May 2011

2-year follow-up of Nevo RES-elution I, a randomised multicentre comparison of the Nevo Sirolimus-eluting coronary stent system using RES technology with the Taxus Liberté Paclitaxel-eluting stent

Published in Volume 7 Supplement M, May 2011

Comparative analysis of DES vs. bare metal stents for the treatment of STEMI- acute and mid-term outcomes

Published in Volume 7 Supplement M, May 2011

Advanced Bifurcation Systems' mother-daughter platform

EuroIntervention Supplement (2010) Vol. 6 (Supplement J) J165-J168

Published in Volume 6 Supplement J, December 2010

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study

EuroIntervention 2010;6:195-205

Published in Volume 6 Number 2, June 2010

Final results of the Inspire trial with the novel MGuard stent

Published in Volume 6 Supplement H, May 2010

Drug-eluting stents versus bare metal stent in saphenous vein graft lesions

Published in Volume 6 Supplement H, May 2010

The use of Sirolimus-eluting CYPHER Select plus coronary stent in patients with acute myocardial infarction (AMI): 1-year results from the e-SELECT registry

Published in Volume 6 Supplement H, May 2010

Stent thrombosis, major bleeding and antiplatelet therapy in the e-SELECT registry: 1-year follow-up of 15,000 patients treated with the Sirolimuseluting CYPHER Select plus stent

Published in Volume 6 Supplement H, May 2010

The use of CYPHER Select® Plus sirolimus-eluting coronary stents in octogenarian patients: one-year results from e-SELECT registry

Published in Volume 6 Supplement H, May 2010

The Sirolimus-eluting CYPHER Select plus coronary stent in diabetic patients, 1-year results from the e-SELECT registry

Published in Volume 6 Supplement H, May 2010

Incidence, predictors and in-hospital outcomes of a large, consecutive cohort of complex patients presenting percutaneous coronary intervention bleeding

Published in Volume 6 Supplement H, May 2010

The use of the Sirolimus-eluting CYPHER Select plus stent in patients treated for multivessel coronary disease, 1-year results from the e-SELECT registry

Published in Volume 6 Supplement H, May 2010

Outcomes of patients under anti-vitamin K treatment receiving the Sirolimuseluting CYPHER Select plus stent, 1-year results from the e-SELECT registry

Published in Volume 6 Supplement H, May 2010

The use of the Sirolimus-eluting CYPHER Select plus coronary stent in patients with renal failure, 1-year results from the e-SELECT registry

Published in Volume 6 Supplement H, May 2010

Impact of renal failure in the clinical outcomes of percutaneous coronary intervention in the drug-eluting stent era - a prospective analysis of unselected patients

Published in Volume 6 Supplement H, May 2010

Coronary bifurcation lesions treated with the novel Nile PAX polymer-free dedicated bifurcation paclitaxel-eluting stent. Preliminary results from the prospective, multicenter BIPAX clinical trial

Published in Volume 6 Supplement H, May 2010

Five-year clinical results of the biolimus A9 eluting stent with biodegradable polymer

Published in Volume 6 Supplement H, May 2010

Twelve-month follow-up of Nevo RES-elution I, a randomised multicentre comparison of the Nevo Sirolimus-eluting coronary stent system using RES technology with the Taxus Liberté paclitaxel-eluting stent

Published in Volume 6 Supplement H, May 2010

Multicentre, prospective, randomised, single blind, consecutive enrollment evaluation of the Elixir Novolimus-eluting coronary stent system with durable polymer compared to the Endeavor Zotarolimus-eluting coronary stent system: 12-month clinical results and 9-month angiographic and IVUS results - the Excella II study

Published in Volume 6 Supplement H, May 2010

Angiographic and intravascular ultrasound findings following implantation of the Endeavor™ zotarolimus-eluting stents in patients from the real-world clinical practice

EuroIntervention 2009;5:355-362

Published in Volume 5 Number 3, August 2009

First 6 months report from the E-Select registry

Published in Volume 5 Supplement E, May 2009

The use of Sirolimus-eluting Cypher Select stent in diabetic patients: a 6-month report from the e-select registry

Published in Volume 5 Supplement E, May 2009

Preliminary experience with the novel MGuard stent system containing a protection net to prevent distal embolisation: results from the Inspire trial

Published in Volume 5 Supplement E, May 2009

Single center, first-in-man study of the Elixir novolimus eluting coronary stent system with durable polymer: 24-month clinical safety and efficacy results

Published in Volume 5 Supplement E, May 2009

Complex patients with coronary artery disease treated with the novel supralimus sirolimus-eluting stents. Preliminary results of the prospective, multicenter, non-randomised E-Series trial

Published in Volume 5 Supplement E, May 2009

Long-term (> 1 year) results of the third generation hydroxyapatite nonpolymer- based sirolimus-eluting stent for the treatment of single de novo coronary lesions

Published in Volume 5 Supplement E, May 2009

EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions

EuroInterv.2008;4:53-58

Published in Volume 4 Number 1, May 2008

The CardioMind coronary stent delivery system: stent delivery on a .014" guidewire platform

EuroInterv.2007;3:154-157

Published in Volume 3 Number 1, May 2007

Bifurcated stents: giving to Caesar what is Caesar\'s

EuroInterv.2007;2:518-525

Published in Volume 2 Number 4, February 2007

Biodegradable-polymer-based, paclitaxel-eluting Infinnium™ stent: 9-Month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study

EuroIntervention 2006;2:310-317 - DOI10.4244/EIJV2I3A56

Published in Volume 2 Number 3, November 2006

The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesions

EuroIntervention 2006;2:295-301 - DOI10.4244/EIJV2I3A54

Published in Volume 2 Number 3, November 2006

Serial assessment of tissue growth inside and outside the stent after implantation of drug-eluting stent in clinical trials. - Does delayed neointimal growth exist?

EuroInterv.2005;1:253-255

Published in Volume 1 Number 3, November 2005

One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - Insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES)

EuroIntervention 2005;1:165-172 - DOI10.4244/EIJV1I2A27

Published in Volume 1 Number 2, August 2005

Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9™ eluting stent with a biodegradable polymer coating

EuroIntervention 2005;1:53-57 - DOI10.4244/EIJV1I1A06

Published in Volume 1 Number 1, May 2005